Concepedia

Hiromi I. Wettersten

HI

20

Publications

1.5K

Citations

16

H-Index

2013

Active since

Affiliations

University of California, Davis(Current)

Sacramento VA Medical Center

Sanford Consortium for Regenerative Medicine

University of California San Diego

University of California Davis Medical Center

Hiromi I. Wettersten is an author at University of California, Davis specializing in medicine, tumor biology, and pharmacology.

Top concepts

MedicinePharmacologyTumor BiologyCancer ResearchCancer Cell BiologyCell BiologyMetabolomicsCancer BiologyHealthUrology

Publications per year

2013–2024

20

Publications

20

Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis

Hiromi I. Wettersten, A. Ari Hakimi, Dexter Morin et al. · Cancer Research · 2015 · 312 citations · Full text

Chemoprevention Strategy, Metabolomic Profiling, Pathology +25

Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis

Guodong Zhang, Dipak Panigrahy, Lisa M. Mahakian et al. · Proceedings of the National Academy of Sciences · 2013 · 285 citations · Full text

Docosahexaenoic Acid, Chemoprevention Strategy, Lipid Peroxidation +21

Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis

Zhe Zhu, Pinar Mesci, Jean Bernatchez et al. · Cell stem cell · 2020 · 179 citations · Full text

Glioma, Viral Pathogenesis, Immunology +6

Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers

Laetitia Seguin, Maria F. Camargo, Hiromi I. Wettersten et al. · Cancer Discovery · 2017 · 101 citations · Full text

Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis

Guodong Zhang, Dipak Panigrahy, Sung Hee Hwang et al. · Proceedings of the National Academy of Sciences · 2014 · 96 citations · Full text

Rows per page

1–5 of 20